Bexarotene salvage therapy in a patient with refractory erythrodermic mycosis fungoides after failure on interferon/PUVA and methotrexate

Dermatol Clin. 2008 Jan:26 Suppl 1:39-41.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Bexarotene
  • Drug Resistance, Neoplasm
  • Humans
  • Interferons / therapeutic use
  • Male
  • Methotrexate / therapeutic use
  • Mycosis Fungoides / drug therapy*
  • Mycosis Fungoides / pathology
  • PUVA Therapy
  • Salvage Therapy*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Tetrahydronaphthalenes / therapeutic use*

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Tetrahydronaphthalenes
  • Interferons
  • Bexarotene
  • Methotrexate